Should Medical Marijuana Be Used To Treat Epileptic Children?
the Clinical Pain Advisor take:
Treating children with medical marijuana has always been a controversial topic, even as support for treating certain conditions with cannabis continues to grow. Some parents are now demanding that politicians and state legislators legalize the use of marijuana for treating epileptic children.
They believe that other medications have had limited success treating seizures and other severe conditions in their children. "I'm watching my daughter die every day," one parent told MSNBC in an interview. "I firmly believe that medical cannabis will help her."
"There's so much that I want for her right now that she just can't do," said another parent. "Just being able to go out and experience life, to be able to go out and play in the yard without fear of seizures starting."
Seventeen states have legalized the use of marijuana-derived cannabidiol (CBD) in children patients since 2014. These states include Utah, Wyoming, Wisconsin, Iowa, Missouri, Oklahoma, Texas, Louisiana, Mississippi, Alabama, Tennessee, Georgia, Florida, South Carolina, North Carolina, Kentucky and Virginia.
Anecdotal evidence suggests that CBD, the non-psychoactive component of the marijuana plant, helps some children with certain conditions. Tetrahydrocannabinol (THC), the part of the plant that produces a high, is also known to treat pain, nausea and insomnia.
Purchasing CBD isn't that simple. For example, some states don't define methods of access in their laws.
As of yet, the FDA has not approved any marijuana-related treatments. The regulatory agency warns parents of using untested treatments on children.
Treating children with medical marijuana has always been a controversial topic, even as support for treating certain conditions with cannabis continues to grow.
Clinical Pain Advisor Articles
- Replacing Sleep, Sedentary Behavior With Physical Activity Beneficial in Knee Osteoarthritis
- The Role of Psychological Factors in Phantom Limb Pain Reviewed
- FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis
- Ozone vs Corticosteroids May Provide Longer-Lasting Effects for Plantar Fasciitis
- Opioid Use Stable in Past Decade Among Commercially Insured, Medicare Beneficiaries
- Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects
- Cannabis May Be Effective for Migraine Treatment
- Medicinal Cannabis May Not Have Opioid-Sparing Effects in Chronic Noncancer Pain
- Integrating Psychological Interventions Into Chronic Pain Management
- Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis
- Pregabalin May Not Improve Analgesia During Medical Abortion
- Investigational Treatment Shows Promise in Chronic Low Back Pain
- Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis
- Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD
- Pain Severity May Partly Mediate the Association Between Depression and Physical Performance in Knee OA